Milstein predicts off-shore competition for nonurgent surgeries, such as major joint replacement and heart procedures, is going to start affecting U.S. prices.
The Veterans Administration, one of the biggest health care providers in the nation, is targeting up to six common surgeries for clinical trials, likely including back surgery and nonurgent gall bladder surgery.